NCT06336044 Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
| NCT ID | NCT06336044 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taumedika s.r.l. |
| Condition | Wrinkle |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-02 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-02 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events
Eligibility Criteria
Inclusion Criteria: * all sexes * caucasic * 18 to 70 years * non smoker Exclusion Criteria: * Pregnancy * milking * smoker * alcohol or drugs abuse * change of BMI during the study * previous facial surgery, implants, permanent treatments * sensitivity to the product * dermatological difficult frame * health weakness * treated with anticoagulants, antihistaminics, corticosteroids, antidepressants and other drugs impacting on the results
Contact & Investigator
Adolfo Gasparetto, MD
STUDY DIRECTOR
Nextrasearch S.r.l.s.
Frequently Asked Questions
Who can join the NCT06336044 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Wrinkle. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06336044 currently recruiting?
Yes, NCT06336044 is actively recruiting participants. Contact the research team at elena.campione@uniroma2.it for enrollment information.
Where is the NCT06336044 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT06336044 clinical trial?
NCT06336044 is sponsored by Taumedika s.r.l.. The principal investigator is Adolfo Gasparetto, MD at Nextrasearch S.r.l.s.. The trial plans to enroll 40 participants.